share_log

HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $75 Price Target

Benzinga ·  Jun 28, 2023 13:01

HC Wainwright & Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $75 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment